StockWatch
·

Eris Lifesciences Ltd Q2 FY26 Results

ERISQ2 FY26 Results
Filing
MetricValue ( Cr)Q1 FY26Q2 FY25
Revenue792.412.5%7.2%
Total Income795.222.5%6.6%
Expenditure622.831.2%1.0%
PBT172.397.6%33.5%
Net Profit134.477.5%39.6%
OPM36.37%0.57pp38.75pp
NPM16.91%0.78pp3.99pp
EPS8.821.9%31.1%
View full financials

Informational and educational content only. Not investment advice.